Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Exchange and Human Albumin for Frailty
NCT07836127Not yet recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in frailty syndrome comparing Plasma Exchange + Human Albumin Group with Plasma Exchange + Human Albumin + IVIg Group (2 arms). Primary endpoint: Efficacy rate of frailty intervention. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
albumin (human)intravenous immunoglobulin G
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT07836127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836127.